Onderneming Gyroscope Therapeutics Holdings plc
Aandelen
VISN
US40382N1037
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 179
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | Delta |
---|---|---|---|
Clinical - Stage Gene Therapy
100,0
%
| 1 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | Delta |
---|---|---|---|
United States
70,0
%
| 1 | 70,0 % | - |
United Kingdom
30,0
%
| 0 | 30,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-02-20 |
Ian Pitfield
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-07-20 |
Jane Hughes
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-10-19 |
Edward Lang
PRN | Corporate Officer/Principal | 44 | 01-06-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 52 | - | |
Director/Board Member | 51 | - | |
Janet Hopkins
BRD | Director/Board Member | 60 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 29 229 659 | 28 937 362 ( 99,00 %) | 0 | 49,50 % |
Aandeel B | 1 | 29 229 659 | 0 | 0 |
Bedrijfsgegevens
Gyroscope Therapeutics Holdings Plc
Gunnels Wood Road
SG1 2FX, Stevenage
+44 14 3890 6770
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |